Jorge Garces

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract CT013: Whole-exome sequencing tumor-informed circulating tumor DNA detection after completion of neoadjuvant treatment predicts non-pCR and distant recurrence in patients with early triple-negative breast cancer (TNBC) — Results from a sub-study of the NSABP B-59/GBG-96-GeparDouze Trial

  Cancer Research · 2026-04-17

• Abstract 1109: The complementary contributions of methylation and protein biomarker classes in a multi-cancer early detection (MCED) test

  Cancer Research · 2026-04-03

• Abstract 1108: Performance of an optimized methylation-protein multi-cancer early detection (MCED) test classifier

  Cancer Research · 2026-04-03

• Performance of an Optimized Methylation-Protein Multi-Cancer Early Detection (MCED) Test Classifier

  medRxiv · 2026-03-04 · 1 citations

• Performance of a multi-target, multi-cancer early detection (MCED) blood test in a prospectively collected cohortPreprint

  medRxiv · 2025-08-26 · 2 citations

• The association of ctDNA with recurrence in patients with stage II-IV colorectal cancer: The β-CORRECT study.

  Journal of Clinical Oncology · 2025-05-28

• 260: TITLE: TRAINING AND TESTING OF A MODIFIED MULTI-CANCER EARLY DETECTION (MCED) BLOOD TEST ALGORITHM FOR DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA WITH INTENDED USE IN HIGH-RISK INDIVIDUALS

  Gastroenterology · 2025-05-01

• Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study.

  Journal of Clinical Oncology · 2025-01-27

• Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study

  Journal of Surgical Oncology · 2025-01-25 · 7 citations

• Abstract A056: Performance of multi-biomarker class reflex testing in a prospectively-collected cohort

  Clinical Cancer Research · 2024-11-13 · 3 citations